I agree to conduct the study as outlined and in accordance with all applicable regulations and guidelines. I agree to maintain the confidentiality of all information received or developed in connection with this protocol. Protocol Title: A randomized, double blind phase II trial of Surgery, Radiation Therapy plus Temozolomide and Pembrolizumab with and without HSPPC-96 in newly diagnosed Glioblastoma (GBM) Protocol Version Date: 03/26/2024 _______________________________________ ___________________ Signature of Principal Investigator Date _________________________________________ Name of Principal Investigator (printed or typed)